Belch, Jill

Professor

  • 15811 Citations
  • 61 h-Index
1980 …2025
If you made any changes in Pure these will be visible here soon.

Research Output 1980 2019

Filter
Comment/debate
2018

New prospects for PCSK9 inhibition

Landmesser, U., Chapman, M. J., Stock, J. K., Amarenco, P., Belch, J. J. F., Borén, J., Farnier, M., Ference, B. A., Gielen, S., Graham, I., Grobbee, D. E., Hovingh, G. K., Luscher, T. F., Piepoli, M. F., Ray, K. K., Stroes, E. S., Wiklund, O., Windecker, S., Zamorano, J. L., Pinto, F. & 3 others, Tokgozoglu, L., Bax, J. J. & Catapano, A. L., 14 Jul 2018, In : European Heart Journal. 39, 27, p. 2600-2601 2 p.

Research output: Contribution to journalComment/debate

Hyperlipoproteinemia Type II
Advisory Committees
Cardiovascular Diseases
Proprotein Convertase 9
2017
91 Citations (Scopus)
52 Downloads (Pure)

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

Landmesser, U., Chapman, M. J., Stock, J. K., Amarenco, P., Belch, J., Borén, J., Farnier, M., Ference, B. A., Gielen, S., Graham, I., Grobbee, D. E., Hovingh, G. K., Luscher, T. F., Piepoli, M., Ray, K. K., Stroes, E. S., Wiklund, O., Windecker, S., Zamorano, J. L., Pinto, F. & 3 others, Tokgozoglu, L., Bax, J. J. & Catapano, A. L., 16 Oct 2017, In : European Heart Journal. 13 p.

Research output: Contribution to journalComment/debate

Open Access
File
Hyperlipoproteinemia Type II
Advisory Committees
Cardiovascular Diseases
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Proprotein Convertase 9
2007
10 Citations (Scopus)

Peripheral arterial disease: a cardiovascular time bomb

Belch, J., Stansby, G., Shearman, C., Brittenden, J., Dugdill, S., Fowkes, G., Jarvis, S., McCann, T., Mimnagh, A., Monkman, D. & Morrell, J., 2007, In : British Journal of Diabetes and Vascular Disease. 7, 5, p. 236-239 3 p.

Research output: Contribution to journalComment/debate

Peripheral Arterial Disease
Contract Services
Intermittent Claudication
Premature Mortality
Risk Management
2003
454 Citations (Scopus)

Critical issues in peripheral arterial disease detection and management: a call to action

Belch, J. J. F., Topol, E. J., Agnelli, G., Bertrand, M., Califf, R. M., Clement, D. L., Creager, M. A., Easton, J. D., Gavin, J. R., Greenland, P., Hankey, G., Hanrath, P., Hirsch, A. T., Meyer, J., Smith, S. C., Sullivan, F. & Weber, M. A., 2003, In : Archives of Internal Medicine. 163, 8, p. 884-892 9 p.

Research output: Contribution to journalComment/debate

1998
44 Citations (Scopus)

Raynaud’s Phenomenon: State of the Art 1998

Ho, M. & Belch, J., 1998, In : Scandinavian Journal of Rheumatology. 27, 5, p. 319-322 4 p.

Research output: Contribution to journalComment/debate

Raynaud Disease
Relaxin
Skin
Connective Tissue Diseases
Nifedipine
10 Citations (Scopus)

UK Scleroderma Group: how can treatment of systemic sclerosis be improved?

Amlot, P., Bacon, P., Belch, J. J. F., Black, C. M., du Bois, R. M., Briggs, D., Denton, C. P., Gough, A., Herrick, A., Jayson, M. I. V., MacGregor, A., MacRae, K., McHugh, N., Maddison, P., Pugh, M., Silman, A. J., Veale, D., Wallington, T. & Welsh, K. I., 1998, In : British Medical Journal. 317, 7154, p. 294 1 p.

Research output: Contribution to journalComment/debate

1995
7 Citations (Scopus)

A circadian-rhythm may exist in healthy controls for soluble P-selectin and platelet count

Kirk, G., Maple, C., McLaren, M. & Belch, J. J. F., 1995, In : Platelets. 6, 6, p. 414-415 2 p.

Research output: Contribution to journalComment/debate

1993

A multidisciplinary approach to vascular disease

Belch, J., 1993, In : Critical Ischaemia. 3, 3, p. 81-86 6 p.

Research output: Contribution to journalComment/debate

1992
4 Citations (Scopus)

Free radicals and their scavenging in stroke

Belch, J., 1992, In : Scottish Medical Journal. 37, 3, p. 67-68 2 p.

Research output: Contribution to journalComment/debate

1 Citation (Scopus)

Is there a role for natural remedies in rheumatoid arthritis?

Belch, J., 1992, In : Scottish Medical Journal. 37, 4, p. 100-102 3 p.

Research output: Contribution to journalComment/debate

1991

Fishing for an arthritis remedy.

Belch, J., 1991, In : Hospital Doctor. C11, 17, p. 40

Research output: Contribution to journalComment/debate

50 Citations (Scopus)

Raynaud's Phenomenon: it's relevance to scleroderma

Belch, J. J. F., 1991, In : Annals of the Rheumatic Diseases. 50, Suppl. 4, p. 839-845 7 p.

Research output: Contribution to journalComment/debate

1984
2 Citations (Scopus)

Value of test for antinuclear antibodies in rheumatic diseases

Steven, M. M., Teh, L. G., Teh, L. S., Pullar, T., Belch, J. J. F., Lewis, D., Parker, J. & Zoma, A., 1984, In : British Medical Journal. 288, 6432, p. 1724-1725 2 p.

Research output: Contribution to journalComment/debate

1983
2 Citations (Scopus)

Raynaud's syndrome: Current trends.

Belch, J. J. F. & Sturrock, R. D., 1983, In : British Journal of Rheumatology. 22, 1, p. 50-55 6 p.

Research output: Contribution to journalComment/debate

1981
18 Citations (Scopus)

Prostacyclin infusion in haemolytic-uraemic syndrome of children

Beattie, T. J., Murphy, A. V., Willoughby, M. L. N. & Belch, J. J. F., 15 Aug 1981, In : BMJ (Clinical Research Ed.). 283, 6289, p. 470 1 p.

Research output: Contribution to journalComment/debate